NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse - PubMed (original) (raw)
NIT-1, a pancreatic beta-cell line established from a transgenic NOD/Lt mouse
K Hamaguchi et al. Diabetes. 1991 Jul.
Abstract
NOD/Lt mice harboring a hybrid rat insulin-promoter/SV40 large T-antigen gene spontaneously develop beta-cell adenomas. NIT-1 is a pancreatic beta-cell line established from one of these transgenic mice. Immunocytochemical staining of passage 18 cells showed most contained insulin, with less than 5% containing glucagon, and none containing pancreatic polypeptide or somatostatin. Glucagon content radioimmunoassayed in cell extracts was only 0.27% of the insulin content. Two-hour insulin secretion at 16.5 mM glucose was 638 ng/10(6) cells (41% of intracellular content) compared to only 1.3 ng glucagon (32% of intracellular content). Stimulated insulin secretion was consistently observed in response to 11 and 16.5 mM glucose between passages 11 and 19. At passage 19, both theophylline and tolbutamide stimulated insulin secretion at 5.5 mM glucose. Northern-blot analysis confirmed high levels of insulin mRNA but only trace glucagon mRNA and undetectable somatostatin mRNA. Interferon-gamma (IFN-gamma)-induced MHC class I RNA expression was correlated with markedly increased antigen expression at the cell surface. Similarly, a MHC-linked "occult" class I-like antigen detected by Cr release assay only after exposure of standard NOD/Lt islet cells to IFN-gamma was strongly induced by IFN-gamma in NIT-1 cells. Cell surface MHC class II antigen was not constitutively expressed on NIT-1 cells and could not be detected after IFN-gamma incubation, despite demonstration of IFN-gamma-induced Aa, Ab, and Li invariant-chain RNA transcripts. Similarly IFN-gamma induction of intercellular adhesion molecule 1 (Icam-1) transcripts was not accompanied by demonstrable cell surface expression of ICAM-1 antigen.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Morphological and functional characterization of beta TC-6 cells--an insulin-secreting cell line derived from transgenic mice.
Poitout V, Stout LE, Armstrong MB, Walseth TF, Sorenson RL, Robertson RP. Poitout V, et al. Diabetes. 1995 Mar;44(3):306-13. doi: 10.2337/diab.44.3.306. Diabetes. 1995. PMID: 7533732 - The H-2KbtsA58 transgenic mouse: a new tool for the rapid generation of novel cell lines.
Noble M, Groves AK, Ataliotis P, Ikram Z, Jat PS. Noble M, et al. Transgenic Res. 1995 Jul;4(4):215-25. doi: 10.1007/BF01969114. Transgenic Res. 1995. PMID: 7655511 Review. - Regeneration of pancreatic endocrine cells in interferon-gamma transgenic mice.
Sarvetnick NE, Gu D. Sarvetnick NE, et al. Adv Exp Med Biol. 1992;321:85-9; discussion 91-3. doi: 10.1007/978-1-4615-3448-8_10. Adv Exp Med Biol. 1992. PMID: 1449085 Review.
Cited by
- Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8+ T cell activity and biomarker during the evolution of Type 1 Diabetes.
Rao C, Cater DT, Roy S, Xu J, Olivera AG, Evans-Molina C, Piganelli JD, Eizirik DL, Mirmira RG, Sims EK. Rao C, et al. bioRxiv [Preprint]. 2024 Sep 19:2024.09.18.613649. doi: 10.1101/2024.09.18.613649. bioRxiv. 2024. PMID: 39345410 Free PMC article. Preprint. - Inhibition of CD226 Co-Stimulation Suppresses Diabetes Development in the NOD Mouse by Augmenting Tregs and Diminishing Effector T Cell Function.
Brown ME, Thirawatananond P, Peters LD, Kern EJ, Vijay S, Sachs LK, Posgai AL, Brusko MA, Shapiro MR, Mathews CE, Bacher R, Brusko TM. Brown ME, et al. bioRxiv [Preprint]. 2024 Jul 19:2024.07.16.603756. doi: 10.1101/2024.07.16.603756. bioRxiv. 2024. PMID: 39071293 Free PMC article. Preprint. - Untangling the genetics of beta cell dysfunction and death in type 1 diabetes.
Robertson CC, Elgamal RM, Henry-Kanarek BA, Arvan P, Chen S, Dhawan S, Eizirik DL, Kaddis JS, Vahedi G, Parker SCJ, Gaulton KJ, Soleimanpour SA. Robertson CC, et al. Mol Metab. 2024 Aug;86:101973. doi: 10.1016/j.molmet.2024.101973. Epub 2024 Jun 22. Mol Metab. 2024. PMID: 38914291 Free PMC article. Review. - RISING STARS: Evidence for established and emerging forms of β-cell death.
Colglazier KA, Mukherjee N, Contreras CJ, Templin AT. Colglazier KA, et al. J Endocrinol. 2024 Jul 4;262(2):e230378. doi: 10.1530/JOE-23-0378. Print 2024 Aug 1. J Endocrinol. 2024. PMID: 38842911 Free PMC article. Review. - Immunopeptidome mining reveals a novel ERS-induced target in T1D.
Wang L, Yang S, Zhu G, Li J, Meng G, Chen X, Zhang M, Wang S, Li X, Pan Y, Huang Y, Wang L, Wu Y. Wang L, et al. Cell Mol Immunol. 2024 Jun;21(6):604-619. doi: 10.1038/s41423-024-01150-0. Epub 2024 Apr 30. Cell Mol Immunol. 2024. PMID: 38689020
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous